Your search for "Press release" return 73 results.
AXA Private Equity provides additional financing to support the development of Ceva >
AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.
Ceva announces scientific breakthrough with the launch of Vectormune® AI >
Vectormune® AI a new generation vaccine for the control of Avian Influenza.
Ceva conducts Global Vaccine Symposium - 2010, October 6-8th >
Do new technologies go with better poultry production and better global health ?
The Perfect Pair is now available >
A great innovation in the protection against Newcastle and Gumboro Diseases
Ceva launches CARDALIS® for dogs with heart failure >
A powerful dual treatment in a single tablet
Mid-year results : Innovation drives Ceva’s growth >
Double-digit growth confirms long term upward trend
Ceva organized 2nd Swine Reproduction Symposium >
Ceva Santé Animale gathers 150 experts from 18 countries in swine reproduction symposium
Ceva develops Vectormune© HVT AIV vaccine to combat Avian Influenza >
USDA approval announced at 8th International Symposium on Avian Influenza
Ceva sponsors 8th International Symposium on Avian Influenza >
Innovation in poultry vaccines and solutions reaches beyond animal health
New commercial licenses for viral vaccine production >
Ceva takes commercial license for ProBioGen’s AGE1.CR® Cell Line for viral vaccine production